3rd Circ. Says Pa. Fen-Phen Suit Barred By Earlier MDL Deal

Law360, New York (January 28, 2013, 7:30 PM EST) -- The Third Circuit on Monday defeated a Pennsylvania couple’s fen-phen product liability suit against Wyeth Pharmaceuticals Inc. and Pfizer Inc., saying in a precedential opinion that their claims are barred by the 1999 settlement covering multidistrict litigation over the diet drugs’ health risks.

A three-judge panel ruled that a Pennsylvania federal court got it right when it enjoined plaintiffs Carmen Cauthen and Ricky Leon Cauthen’s suit, saying they did not qualify for a cause of action exemption that would have allowed them to proceed with the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.